RALTEGRAVIR

UNII:	22VKV8053U
Formula:	C₂₀H₂₁FN₆O₅
Preferred Substance Name:	RALTEGRAVIR
InChIKey:	CZFFBEXEKNGXKS-UHFFFAOYSA-N

518048-05-0
4-PYRIMIDINECARBOXAMIDE, N-((4-FLUOROPHENYL)METHYL)-1,6-DIHYDRO-5-HYDROXY-1-METHYL-2-(1-METHYL-1-(((5-METHYL-1,3,4-OXADIAZOL-2-YL)CARBONYL)AMINO)ETHYL)-6-OXO-
L000900612
L-000900612
MK-0518
N-(2-(4-(4-FLUOROBENZYLCARBAMOYL)-5-HYDROXY-1-METHYL-6-OXO-1,6- DIHYDROPYRIMIDIN-2-YL)PROPAN-2-YL)-5-METHYL-1,3,4-OXADIAZOLE-2-CARBOXAMIDE
N-(4-FLUOROBENZYL)-5-HYDROXY-1-METHYL-2-(1-METHYL-1-(((5-METHYL-1,3,4-OXADIAZOL-2-YL)CARBONYL)AMINO)ETHYL)-6-OXO-1,6-DIHYDROPYRIMIDINE-4-CARBOXAMIDE
RALTEGRAVIR [EMA EPAR]
RALTEGRAVIR [INN]
RALTEGRAVIR [MART.]
RALTEGRAVIR [MI]
RALTEGRAVIR [VANDF]
RALTEGRAVIR [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RALTEGRAVIR

Synonyms and Mappings

Resources